{"id":189278,"date":"2026-07-03T03:43:14","date_gmt":"2026-07-03T09:13:14","guid":{"rendered":"https:\/\/newslink360.space\/?p=189278"},"modified":"2026-07-03T03:43:14","modified_gmt":"2026-07-03T09:13:14","slug":"touch-care-and-aromatherapy-in-cancer","status":"publish","type":"post","link":"https:\/\/newslink360.space\/?p=189278","title":{"rendered":"Touch Care and Aromatherapy in Cancer"},"content":{"rendered":"


\n<\/p>\n

\n

TOUCH care and aromatherapy appeared feasible and safe for hospitalized patients with thoracic malignancies receiving cancer treatment.<\/p>\n

A prospective single-arm feasibility study evaluated a combined supportive care intervention<\/a> in 87 hospitalized patients with thoracic malignancies, most of whom had advanced disease. All patients completed the intervention, and no exacerbation of preexisting symptoms was observed.<\/p>\n

The intervention paired 20 minutes of foot touch care with aromatherapy delivered through an aroma bead sachet placed on the patient\u2019s chest. The essential oil was not applied directly to the skin, a design choice intended to reduce the risk of skin irritation in patients undergoing chemotherapy, radiotherapy, or best supportive care.<\/p>\n

Safety Findings Support Further Study<\/h2>\n

All 87 evaluable patients completed the touch care and aromatherapy intervention. Intervention-related adverse events or discomfort occurred in five patients (5.7%), and all were minor. One patient experienced Grade 1 fatigue after the intervention, while four reported aroma-related discomfort. These issues were managed without discontinuation, including by moving the aroma bead sachet farther from the nose.<\/p>\n

The cohort included patients with non-small cell lung cancer, small-cell lung cancer, thymic cancer, and malignant pleural mesothelioma. Overall, 85% had non-small cell lung cancer, and 56% had stage IV disease. Nearly half received best supportive care alone, while others received chemotherapy, radiotherapy, chemoradiotherapy, or surgery.<\/p>\n

Symptom and Stress Measures Improved<\/h2>\n

Among patients with symptoms before the intervention, fatigue improved in 74.1%, pain in 75.7%, cold feet in 94.4%, and heaviness of the legs or body in 100%. Less common symptoms, including insomnia, cough, loss of appetite, numbness, taste or smell disturbance, nausea, and constipation, also improved in many patients, although patient numbers were small.<\/p>\n

Five of six subjective physical and emotional status items significantly improved after the intervention, including well-being, warmth, sluggishness, pain, and relaxation. Sleepiness improved numerically but was not statistically significant.<\/p>\n

Objective physiologic assessments also suggested a relaxation response. Heart rate decreased significantly, while high-frequency heart rate variability, SDNN, and RMSSD increased, indicating enhanced parasympathetic activity. Salivary \u03b1-amylase and cortisol levels also fell significantly after treatment.<\/p>\n

The authors emphasized that the study was not powered to confirm symptom efficacy and lacked a control group. Still, the findings support additional randomized research into touch care and aromatherapy as a low-burden supportive care approach for hospitalized patients with thoracic malignancies.<\/p>\n

Reference<\/strong>
Tamai E et al. Feasibility and safety of combined touch care and aromatherapy in hospitalized patients with thoracic malignancies: A prospective single-arm study. Asia-Pacific Journal of Oncology Nursing. 2026;13.<\/p>\n

Featured Image: ABCreative on Adobe Stock.<\/p>\n<\/div>\n


\n
Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

TOUCH care and aromatherapy appeared feasible and safe for hospitalized patients with thoracic malignancies receiving cancer treatment. A prospective single-arm feasibility study evaluated a combined supportive care intervention in 87 hospitalized patients with thoracic malignancies, most of whom had advanced disease. All patients completed the intervention, and no exacerbation of preexisting symptoms was observed. The … Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":189279,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7],"tags":[],"class_list":["post-189278","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-national-news"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/newslink360.space\/wp-content\/uploads\/2026\/07\/AdobeStock_1307592583.jpeg","jetpack_likes_enabled":true,"jetpack-related-posts":[{"id":185408,"url":"https:\/\/newslink360.space\/?p=185408","url_meta":{"origin":189278,"position":0},"title":"Radiation Therapy May Carry Sexual Health Risks \u2013 EMJ","author":"Ajay Kumar Verma","date":"June 25, 2026","format":false,"excerpt":"RADIATION THERAPY for gynecologic cancers carries lasting adverse effects on sexual health, a new systematic review has found.1 Patient-Reported Outcomes Researchers analysed a total of 26 studies, comprising data from 5,646 patients. In analysis, 11 studies focused on cervical cancer, seven on endometrial cancer, and eight on mixed gynecological malignancies.\u2026","rel":"","context":"In "National News"","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/9am-repro-2.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/9am-repro-2.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/9am-repro-2.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/9am-repro-2.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":174807,"url":"https:\/\/newslink360.space\/?p=174807","url_meta":{"origin":189278,"position":1},"title":"New genomic test may help millions of breast cancer patients avoid chemotherapy – CNBC TV18","author":"Ajay Kumar Verma","date":"May 30, 2026","format":false,"excerpt":"New genomic test may help millions of breast cancer patients avoid chemotherapy\u00a0\u00a0CNBC TV18Millions of breast cancer patients could safely avoid chemotherapy, study suggests\u00a0\u00a0BBCGroundbreaking genomic test could spare millions of breast cancer patients chemotherapy\u00a0\u00a0The GuardianSkip the chemo: Millions of breast cancer patients could be spared chemotherapy with groundbreaking genomic test\u00a0\u00a0The Times\u2026","rel":"","context":"In "National News"","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/05\/J6_coFbogxhRI9iM864NL_liGXvsQp2AupsKei7z0cNNfDvGUmWUy20nuUhkREQyrpY4bEeIBucs0-w300-rw.webp?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":186463,"url":"https:\/\/newslink360.space\/?p=186463","url_meta":{"origin":189278,"position":2},"title":"Prostate Volume Impacts Fusion Biopsy Cancer Detection","author":"Ajay Kumar Verma","date":"June 27, 2026","format":false,"excerpt":"INCREASING prostate volume is associated with significantly lower prostate cancer detection rates using MRI\u2013ultrasound (MRI\u2013US) fusion-guided\u00a0biopsy,\u00a0according to a new study,\u00a0highlighting the need to consider gland size when planning diagnostic strategies.\u00a0 MRI\u2013US fusion biopsy has become\u00a0an important tool\u00a0in prostate cancer diagnosis, combining multiparametric MRI findings with targeted ultrasound-guided sampling. However, enlarged\u2026","rel":"","context":"In "National News"","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/1pm-urol-2.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/1pm-urol-2.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/1pm-urol-2.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/1pm-urol-2.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":185518,"url":"https:\/\/newslink360.space\/?p=185518","url_meta":{"origin":189278,"position":3},"title":"Hidradenitis Suppurativa and ICIs – AMJ","author":"Ajay Kumar Verma","date":"June 25, 2026","format":false,"excerpt":"HIDRADENITIS suppurativa may newly develop or flare in some patients receiving immune checkpoint inhibitor therapy. Hidradenitis Suppurativa During Cancer Immunotherapy Immune checkpoint inhibitors have transformed cancer treatment, but their immune-mediated effects can extend beyond tumor control. A new scoping review suggests that hidradenitis suppurativa may emerge after immune checkpoint inhibitor\u2026","rel":"","context":"In "National News"","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/AdobeStock_837966512.jpeg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/AdobeStock_837966512.jpeg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/AdobeStock_837966512.jpeg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/AdobeStock_837966512.jpeg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":182594,"url":"https:\/\/newslink360.space\/?p=182594","url_meta":{"origin":189278,"position":4},"title":"Hypopigmented Mycosis Fungoides Shows Low Risk","author":"Ajay Kumar Verma","date":"June 19, 2026","format":false,"excerpt":"A LARGE multicentre cohort study has found that hypopigmented mycosis fungoides (HMF) in adults generally follows an indolent clinical course, with most patients presenting with early-stage disease and responding well to skin-directed therapies. Insights from a Multicentre Hypopigmented Mycosis Fungoides Study The retrospective study analysed 224 adults with biopsy-confirmed HMF\u2026","rel":"","context":"In "National News"","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/2pm-derm-5.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/2pm-derm-5.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/2pm-derm-5.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/2pm-derm-5.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":175949,"url":"https:\/\/newslink360.space\/?p=175949","url_meta":{"origin":189278,"position":5},"title":"Breakthrough drug nearly doubles survival with advanced pancreatic cancer \u2013 an oncologist explains how daraxonrasib overcame an \u2018undruggable\u2019 disease – The Conversation","author":"Ajay Kumar Verma","date":"June 2, 2026","format":false,"excerpt":"Breakthrough drug nearly doubles survival with advanced pancreatic cancer \u2013 an oncologist explains how daraxonrasib overcame an \u2018undruggable\u2019 disease\u00a0\u00a0The ConversationDaily pill doubles survival time for pancreatic cancer patients\u00a0\u00a0BBC\u2018Landmark\u2019 pancreatic cancer drug keeps patients alive for twice as long\u00a0\u00a0The Washington PostDaily pill can double survival time for world\u2019s deadliest cancer, trial\u2026","rel":"","context":"In "National News"","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/05\/J6_coFbogxhRI9iM864NL_liGXvsQp2AupsKei7z0cNNfDvGUmWUy20nuUhkREQyrpY4bEeIBucs0-w300-rw.webp?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pgnRh4-NeS","_links":{"self":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts\/189278","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=189278"}],"version-history":[{"count":0,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts\/189278\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/media\/189279"}],"wp:attachment":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=189278"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=189278"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=189278"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}